Literature DB >> 2143053

Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype.

J R Korenberg1, H Kawashima, S M Pulst, T Ikeuchi, N Ogasawara, K Yamamoto, S A Schonberg, R West, L Allen, E Magenis.   

Abstract

Down syndrome (DS) is a major cause of mental retardation and heart disease. Although it is usually caused by the presence of an extra chromosome 21, a subset of the diagnostic features may be caused by the presence of only band 21q22. We now present evidence that significantly narrows the chromosomal region responsible for several of the phenotypic features of DS. We report a molecular and cytogenetic analysis of a three-generation family containing four individuals with clinical DS as manifested by the characteristic facial appearance, endocardial cushion defect, mental retardation, and probably dermatoglyphic changes. Autoradiograms of quantitative Southern blots of DNAs from two affected sisters, their carrier father, and a normal control were analyzed after hybridization with two to six unique DNA sequences regionally mapped on chromosome 21. These include cDNA probes for the genes for CuZn-superoxide dismutase (SOD1) mapping in 21q22.1 and for the amyloid precursor protein (APP) mapping in 21q11.2-21.05, in addition to six probes for single-copy sequences: D21S46 in 21q11.2-21.05, D21S47 and SF57 in 21q22.1-22.3, and D21S39, D21S42, and D21S43 in 21q22.3. All sequences located in 21q22.3 were present in three copies in the affected individuals, whereas those located proximal to this region were present in only two copies. In the carrier father, all DNA sequences were present in only two copies. Cytogenetic analysis of affected individuals employing R and G banding of prometaphase preparations combined with in situ hybridization revealed a translocation of the region from very distal 21q22.1 to 21qter to chromosome 4q. Except for a possible phenotypic contribution from the deletion of chromosome band 4q35, these data provide a molecular definition of the minimal region of chromosome 21 which, when duplicated, generates the facial features, heart defect, a component of the mental retardation, and probably several of the dermatoglyphic changes of DS. This region may include parts of bands 21q22.2 and 21q22.3, but it must exclude the genes S0D1 and APP and most of band 21q22.1, specifically the region defined by S0D1, SF57 and D21S47.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143053      PMCID: PMC1683719     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Normal phenotype and partial trisomy for the G positive region of chromosome 21.

Authors:  A Daniel
Journal:  J Med Genet       Date:  1979-06       Impact factor: 6.318

2.  [Partial trisomy 21 (21q21 - 21q22.2)].

Authors:  M Poissonnier; B Saint-Paul; B Dutrillaux; M Chassaigne; P Gruyer; G de Blignières-Strouk
Journal:  Ann Genet       Date:  1976-03

3.  Clinical diagnosis of Down's syndrome.

Authors:  J F Jackson; E R North; J G Thomas
Journal:  Clin Genet       Date:  1976-05       Impact factor: 4.438

4.  Localization of the beta-globin gene to 11p15 by in situ hybridization: utilization of chromosome 11 rearrangements.

Authors:  R E Magenis; T A Donlon; D R Tomar
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Simultaneous fluorescent staining of R bands and specific heterochromatic regions (DA-DAPI bands) in human chromosomes.

Authors:  D Schweizer
Journal:  Cytogenet Cell Genet       Date:  1980

6.  Pierre-Robin anomalad, moderate mental retardation and distal 4q deletion.

Authors:  J P Fryns; J Timmermans; J Hoedemaekers; L Emmery; H Van den Berghe
Journal:  Ann Genet       Date:  1981

7.  Terminal deletion(4)(q33) in a male infant.

Authors:  J Stamberg; E W Jabs; E Elias
Journal:  Clin Genet       Date:  1982-02       Impact factor: 4.438

8.  Trisomy 21 for the region 21q223: identification by high-resolution R-banding patterns.

Authors:  J F Mattei; M G Mattei; M A Baeteman; F Giraud
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality.

Authors:  J L Huret; J M Delabar; F Marlhens; A Aurias; A Nicole; M Berthier; J Tanzer; P M Sinet
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

10.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

View more
  65 in total

1.  A case of apparent trisomy 21 without the Down's syndrome phenotype.

Authors:  D Avramopoulos; I Kennerknecht; G Barbi; D Eckert; J M Delabar; C Maunoury; A Hallberg; M B Petersen
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  Comparison of total cellular DNA, mRNA, and rRNA levels between normals and Down syndrome patients.

Authors:  C I McQuillan; K H Choo
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Deletion of chromosome 21 and normal intelligence: molecular definition of the lesion.

Authors:  J R Korenberg; D K Kalousek; G Anneren; S M Pulst; J G Hall; C J Epstein; D R Cox
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

Review 4.  The cognitive phenotype of Down syndrome: insights from intracellular network analysis.

Authors:  Avi Ma'ayan; Katheleen Gardiner; Ravi Iyengar
Journal:  NeuroRx       Date:  2006-07

5.  Isolation, characterization, and regional mapping of microclones from a human chromosome 21 microdissection library.

Authors:  J Yu; J Hartz; Y Xu; R M Gemmill; J R Korenberg; D Patterson; F T Kao
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

6.  Protocols to establish genotype-phenotype correlations in Down syndrome.

Authors:  C J Epstein; J R Korenberg; G Annerén; S E Antonarakis; S Aymé; E Courchesne; L B Epstein; A Fowler; Y Groner; J L Huret
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

7.  Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses.

Authors:  Donna K Slonim; Keiko Koide; Kirby L Johnson; Umadevi Tantravahi; Janet M Cowan; Zina Jarrah; Diana W Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

Review 8.  Medical genetics.

Authors:  M Super
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

9.  Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Authors:  Li Zhang; Kai Meng; Xiaoling Jiang; Chunhong Liu; Annie Pao; Pavel V Belichenko; Alexander M Kleschevnikov; Sheena Josselyn; Ping Liang; Ping Ye; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2013-09-16       Impact factor: 6.150

10.  Down syndrome phenotypes: the consequences of chromosomal imbalance.

Authors:  J R Korenberg; X N Chen; R Schipper; Z Sun; R Gonsky; S Gerwehr; N Carpenter; C Daumer; P Dignan; C Disteche
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.